News
-
4 October 2017
Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer -
18 September 2017
Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases -
7 July 2017
Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK -
3 July 2017
Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline -
5 June 2017
Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting -
1 June 2017
Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting -
12 May 2017
Abbas Hussain Joins the Board of Immunocore as Non-Executive Director -
8 May 2017
Immunocore identifies second novel ImmTAC® in the GSK collaboration -
5 April 2017
Immunocore Publishes Gender Pay Report -
28 February 2017
Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference